Accreditation: 8.50 ABIM MOC II | 8.50 ACPE Pharmacy | 8.50 Nursing Contact Hours | 8.50 AMA PRA Category 1 Credit™
Venue: InterContinental Houston, 6750 Main Street, Houston , TX, United States
Official conference page for Best of Hematology & Breast Cancer™ 2026, Houston. https://binaytara.org/projects/conferences/best-of-hematology-breast-cancer-2026-houston
Identification and mitigation of potential conflicts of interest
All conflict of interest has been identified and mitigated for individuals in control of contents.
Planning committee disclosure statement
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Conference Chairs
Awaiting faculty disclosure.
has a financial relationship (Employee) with Baylor College of Medicine.
Session Chairs
Awaiting faculty disclosure.
No, I have not had a financial relationship with an ineligible company within the past 24 months.
Awaiting faculty disclosure.
has a financial relationship (Advisor) with Pfizer.
has a financial relationship (Other) with Amgen; financial relationship (Grant Or Contract) with Aveo; financial relationship (Other) with Biogen IDEC; financial relationship (Grant Or Contract) with Celgene; financial relationship (Grant Or Contract) with DeNovo; financial relationship (Grant Or Contract) with Incyte.
has a financial relationship (Professional Services) with Pfizer; financial relationship (Professional Services) with Novartis; financial relationship (Professional Services) with Seagen; financial relationship (Professional Services) with Biotheranostics; financial relationship (Professional Services) with Gilead Sciences; financial relationship (Professional Services) with Astra Zeneca/Daiichi Sankyo.
Faculty
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
has a financial relationship (Researcher) with BMS, Summit Therapeutics; financial relationship (Consultant) with BostonGene, GE HealthCare, AstraZeneca, Aptitude Health, PreludeDX, Community Health Media, Agendia, Stemline; financial relationship (Professional Service) with Chair of Lobular Breast Cancer Alliance; financial relationship (Employee) with MD Anderson Cancer Center.
No, I have not had a financial relationship with an ineligible company within the past 24 months.
Awaiting faculty disclosure.
has a financial relationship (Researcher) with American Society of Clinical Oncology; financial relationship (Researcher) with Breast Cancer Research Foundation; financial relationship (Researcher) with Bristol Meyers Squibb Foundation; financial relationship (Researcher) with National Institute of Health.
has a financial relationship (Advisor) with 280 Bio; financial relationship (Advisor) with ADC Therapeutics Medical Expert Advisory Board; financial relationship (Speaker) with Consulting/Scientific Advisory Board/Speaking.
has a financial relationship (Researcher) with Bristol Myers Squibb; financial relationship (Consultant) with FACT; financial relationship (Consultant) with Fate Therapeutics; financial relationship (Advisor) with Kite; financial relationship (Researcher) with Marker Therapeutics; financial relationship (Advisor) with Novartis.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
has a financial relationship (Advisor) with Pfizer.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
has a financial relationship (Speaker) with Dava Onology.
Awaiting faculty disclosure.
Staff
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
